EGFR and lung carcinoma: Hypomethylation of DAPL1 also is associated with the prognosis of the EGFR Del19 mutation subtype in lung cancer patients, and lung cancer patients showing hypomethylation of DAPL1 have significantly longer overall survival times [6].